Idiopathic Pulmonary Hemosiderosis
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Idiopathic Pulmonary Hemosiderosis

What is the definition of Idiopathic Pulmonary Hemosiderosis?
Idiopathic pulmonary hemosiderosis is a rare disease characterized by repeated episodes of bleeding into the lungs, which can cause anemia and lung disease. The body is able to remove most of the blood from the lungs, but a large amount of iron is left behind. Over time, this iron can cause permanent damage to the lungs (fibrosis). Symptoms can resemble pneumonia and include coughing, coughing up blood (hemoptysis), difficulty breathing, and wheezing. The cause of Idiopathic pulmonary hemosiderosis is unknown. Diagnosis is based on ruling out other kinds of pulmonary hemosiderosis, and tests may include imaging, laboratory tests, and a lung biopsy.
What are the alternative names for Idiopathic Pulmonary Hemosiderosis?
  • Idiopathic pulmonary hemosiderosis
  • Siderosis
  • Alveolar hypoventilation syndrome
  • Hemosiderosis, pulmonary, with deficiency of gamma-a globulin
  • Pulmonary hemosiderosis
Who are the top Idiopathic Pulmonary Hemosiderosis Local Doctors?
Advanced in Idiopathic Pulmonary Hemosiderosis
Family Medicine
Advanced in Idiopathic Pulmonary Hemosiderosis
Family Medicine

Texas Health Family Care

10900 Founders Way, Suite 103, 
Fort Worth, TX 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

William Drake is a primary care provider, practicing in Family Medicine in Fort Worth, Texas. Dr. Drake is rated as an Advanced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Cirrhosis, Familial Combined Hyperlipidemia, Xanthoma, and High Cholesterol. Dr. Drake is currently accepting new patients.

Experienced in Idiopathic Pulmonary Hemosiderosis
Family Medicine
Experienced in Idiopathic Pulmonary Hemosiderosis
Family Medicine

Texas Health Family Care

8440 Walnut Hill Lane, Suite 300, 
Dallas, TX 
Languages Spoken:
English, Portuguese
Accepting New Patients

Cynthia Shughrue is a primary care provider, practicing in Family Medicine in Dallas, Texas. Dr. Shughrue is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and High Cholesterol. Dr. Shughrue is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Idiopathic Pulmonary Hemosiderosis
Family Medicine
Experienced in Idiopathic Pulmonary Hemosiderosis
Family Medicine

Franciscan Medical Clinic - Enumclaw

3021 Griffin Ave, 
Enumclaw, WA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Jennifer Sweet is a primary care provider, practicing in Family Medicine in Enumclaw, Washington. Dr. Sweet is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Obesity in Children, Obesity, Hypothyroidism, Melorheostosis, and Intrauterine Device Insertion. Dr. Sweet is board certified in American Board Of Family Medicine. Dr. Sweet is currently accepting new patients.

What are the latest Idiopathic Pulmonary Hemosiderosis Clinical Trials?
Leflunomide is Safe and Effective for the Induction and Maintenance of Idiopathic Pulmonary Hemosiderosis Remission

Summary: The goal of this clinical trial is to compare Leflunomide in Idiopathic pulmonary hemosiderosis. The main questions it aims to answer are: * The efficacy and safety of Leflunomide in Idiopathic pulmonary hemosiderosis * The mechanism of leflunomide in treating Idiopathic pulmonary hemosiderosis Participants will be treated with leflunomide plus stroid. A comparison group: Researchers will compare ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center